Search research articles
Contact Us
Filters
Showing results (141-150 of 179) with videos related to
Page
of 18
Sort By:
Journal of Pharmacological Sciences
|
September 27, 2008
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Robert Klicek, Marko Sever, Bozo Radic, et al.
World Journal of Gastroenterology
|
August 7, 2023
Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect
Luka Kalogjera, Ivan Krezic, Ivan Maria Smoday, et al.
Vascular Pharmacology
|
March 7, 2018
Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157
Jakša Vukojević, Marko Siroglavić, Katarina Kašnik, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 28, 2023
Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy
Sanja Strbe, Ivan Maria Smoday, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review
Danijel Matek, Irena Matek, Mladen Japjec, et al.
Life Sciences
|
February 8, 2011
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions
Spomenko Ilic, Domagoj Drmic, Sandra Franjic, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity
Predrag Sikiric, Alenka Boban Blagaic, Sanja Strbe, et al.
Journal of Pharmacological Sciences
|
April 25, 2007
Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157
Ivan Dobric, Petar Drvis, Igor Petrovic, et al.
World Journal of Gastroenterology
|
January 24, 2018
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
Antonija Duzel, Josipa Vlainic, Marko Antunovic, et al.
Current Pharmaceutical Design
|
July 13, 2018
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing
Sven Seiwerth, Rudolf Rucman, Branko Turkovic, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 179) with videos related to
Sort By:
Page
of 18
Journal of Pharmacological Sciences
|
September 27, 2008
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Robert Klicek, Marko Sever, Bozo Radic, et al.
World Journal of Gastroenterology
|
August 7, 2023
Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect
Luka Kalogjera, Ivan Krezic, Ivan Maria Smoday, et al.
Vascular Pharmacology
|
March 7, 2018
Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157
Jakša Vukojević, Marko Siroglavić, Katarina Kašnik, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 28, 2023
Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy
Sanja Strbe, Ivan Maria Smoday, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review
Danijel Matek, Irena Matek, Mladen Japjec, et al.
Life Sciences
|
February 8, 2011
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions
Spomenko Ilic, Domagoj Drmic, Sandra Franjic, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity
Predrag Sikiric, Alenka Boban Blagaic, Sanja Strbe, et al.
Journal of Pharmacological Sciences
|
April 25, 2007
Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157
Ivan Dobric, Petar Drvis, Igor Petrovic, et al.
World Journal of Gastroenterology
|
January 24, 2018
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
Antonija Duzel, Josipa Vlainic, Marko Antunovic, et al.
Current Pharmaceutical Design
|
July 13, 2018
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing
Sven Seiwerth, Rudolf Rucman, Branko Turkovic, et al.
Page
of 18